Watch 2015 World Medical Innovation Forum | Disruptive Dozen – 8
8: Molecular Intervention Using Minimally-Invasive Technology
Leading CNS faculty from the Brigham and Women’s Hospital, Massachusetts General Hospital, and McLean Hospital nominated the technologies they believe will have the greatest impact on neurological care in the next decade. A panel of senior Partners neuroscience leaders chose the final list and ranking of these 12 disruptive technologies. This intriguing and fun session will let you in on how the experts view the future in their field.
Rudolph Tanzi, PhD, Director, Genetics and Aging Research Unit, MassGeneral Institute for Neurodegenerative Disease & Joseph P. and Rose F. Kennedy Professor of Neurology, Harvard Medical School
Matthew Frosch, MD, PhD, Director, Neuropathology Service, MGH; Lawrence J. Henderson Associate Professor of Pathology and Health Sciences & Technology, Harvard Medical School; Core Leader, Neuropathology Core, Massachusetts Alzheimer’s Disease Research Center
Sorry, the comment form is closed at this time.